The EU Falsified Medicines Directive: 5 steps to compliance

The Falsified Medicines Directive (FMD) 2011/62/EU, which comes into full force on the 9th February 2019, aims to increase the security of the manufacturing process and delivery of medicines throughout Europe, providing greater protection for patients.

Organizations that have not yet become compliant must now act fast to ensure they do not fall foul of the regulation. So, what can be done to make sure FMD compliance projects are completed in time and that the chosen solutions are robust enough to guarantee immediate compliance? Christian Taylor, Serialization Business Consultant at Zetes, provides his five-step plan to becoming FMD compliant, they include:

• Review existing processes.
• Frame projects.
• Consider technology.
• The combination of people and technology.
• Add values to the business.

Pharma Logistics IQ Special Report: Combatting Counterfeit Activity in the Pharma industry

Discover the key vulnerabilities to counterfeit activity in the supply chain and solutions to improve operational flexibility, build long-term resilience and cut supply chain costs. Download the Report.

Learn More

1. Review existing processes

   With the legislation fast approaching, there is growing urgency to find suitable solutions. However, as FMD compliance needs to be built into day-to-day operations, it requires a careful and considered process review.

   Organizations should proactively look to implement solutions that bring minimal disruption to their current working processes, drive efficiency and are simple to use. Operational team engagement in the plan is needed if businesses are to achieve full compliance and effective delivery. This, along with a well-managed implementation, that is supported by solid training and open communications, will result in a rapid launch.

   RELATED: Read our guideline for EU FMD Implementation

2. Frame projects

   Organizations not only need to focus on making sure they have compliance ahead of the 9th February deadline, but they must also ensure that any implemented FMD solutions are built upon flexible foundations. This flexibility will allow them to encompass broader roadmap principles such as automation for decommissioning, returns, consolidation and aggregation or adding a visibility layer for reporting and insight beyond the audit trail.

   Examining the flexibility that an FMD solution can provide will allow businesses to think big, start small, scale fast and have a platform for growth in the future. 

   Furthermore, Good Distribution Practice (GDP) requires the capturing and storing of batch-level information. Whereas, FMD requires organizations to capture and share item level serialized data. Businesses, therefore, need to identify datasets, sources and recipients. This will be vital in ensuring future scalability, including the ability to consolidate, aggregate products and data and share this information in real time to enable other parties to mass decommission if needed.  

3. Consider technology

   Technology can play a key role in error reduction. The choice of technology is largely based on the volume throughput and the environment for capturing data. Large scale operations need to weigh up the value of manual scanning against semi-automated and fully automated options to ensure high accuracy for higher throughput volumes. Smaller scale operations may be able to get by with basic handheld devices but they must have operational procedures and process controls in place that are robust enough to ensure accuracy.

   Regardless of its size, an organization should try to avoid serialization systems that are heavily reliant on a specific hardware or software. Such restraints could restrict its ability to take advantage of any new processes or technology without having to re-implement a whole new project further down the line. 

“The first step is to acknowledge the problem, and then you can move on to risk management and analysis”

With insight from sector experts, learn how to identify weak points in your pharma supply chain and how you can secure them. Download the Pharma Logistics IQ report.

Learn More

4. The combination of people and technology

   The successful deployment of an FMD solution requires the buy-in of not only compliance teams and the IT department but also wider operational teams and those using the solution day-to-day. It is vital that any solution fits within the business environment.

   Operational staff should also be made aware of the implications of FMD, however, organizations shouldn’t find themselves in a situation where an employee on the warehouse floor is making decisions that affect the legal standing of the business. Instead, it should ensure that users are armed with the most appropriate technology to help them with compliance.

5. Add value to the business

   Typically, compliance is viewed as a business burden and something that is unlikely to create direct value. By implementing a solution that can optimize supply chains, update data flows, break down operational silos and enable tighter internal and external collaboration, substantial value will be unlocked.

   Additionally, adding automation and digitizing messages to complement the physical flow of the supply chain, will not only increase efficiency and reduce errors but also provide greater actionable insight to optimize the future process, while providing early alerts of any potential risks.

Did you enjoy this article? Why not read our three easy ways to optimize the FMD decommissioning process